Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PVLA | AMGN | BMY | GILD | VRTX |
| Company | Palvella Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 14.90 | 260.22 | 56.68 | 90.89 | 402.99 |
| High | 15.67 | 265.21 | 57.67 | 91.51 | 410.81 |
| Low | 14.10 | 259.35 | 56.52 | 90.51 | 401.54 |
| Last | 14.73 | 262.06 | 57.14 | 90.63 | 408.32 |
| Change | -0.03 | +3.47 | +0.46 | -0.60 | +5.83 |
| % Change | -0.17% | +1.34% | +0.81% | -0.66% | +1.45% |
| Volume | 69,200 | 3,173,700 | 10,814,500 | 5,811,900 | 1,679,900 |
| 20-Day Average Volume | 43,315 | 3,732,530 | 11,508,220 | 6,340,795 | 1,958,855 |
| Previous Close | 14.76 | 258.59 | 56.68 | 91.23 | 402.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.40 | 265.13 | 57.02 | 92.21 | 428.83 |
| 20-Day Raw Stochastic | 57.51% | 32.81% | 44.49% | 26.91% | 30.90% |
| 20-Day Relative Strength | 52.49% | 36.48% | 51.59% | 47.77% | 37.69% |
| Weighted Alpha | -45.49 | -18.71 | +19.91 | +14.23 | -11.40 |
| Today's Opinion | 8% Sell | 88% Sell | 88% Buy | 64% Buy | 88% Sell |
| Previous Opinion | 8% Sell | 88% Sell | 56% Buy | 64% Buy | 88% Sell |
| Last Month's Opinion | 72% Buy | 72% Sell | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +22.75% since 12/30/24 | +1.06% since 12/30/24 | +1.93% since 12/30/24 | -1.50% since 12/30/24 | +2.25% since 12/30/24 |
| Low | 11.28 on 01/02/25 | 257.05 on 01/06/25 | 55.93 on 12/31/24 | 90.32 on 01/06/25 | 399.00 on 01/06/25 |
| High | 15.67 on 01/07/25 | 265.21 on 01/07/25 | 57.67 on 01/07/25 | 92.98 on 12/31/24 | 411.65 on 01/03/25 |
| 1-Month | |||||
| %Chg | -9.80% since 12/06/24 | -3.86% since 12/06/24 | -3.77% since 12/06/24 | -1.63% since 12/06/24 | -11.64% since 12/06/24 |
| Low | 11.17 on 12/30/24 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 17.36 on 12/10/24 | 280.00 on 12/09/24 | 59.76 on 12/09/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -8.96% since 10/07/24 | -17.45% since 10/07/24 | +6.92% since 10/07/24 | +7.34% since 10/07/24 | -8.98% since 10/07/24 |
| Low | 11.17 on 12/30/24 | 253.30 on 12/19/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 | 377.85 on 12/19/24 |
| High | 17.70 on 11/06/24 | 329.17 on 10/11/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +75.36% since 07/05/24 | -15.70% since 07/05/24 | +44.07% since 07/05/24 | +35.90% since 07/05/24 | -13.96% since 07/05/24 |
| Low | 6.20 on 07/12/24 | 253.30 on 12/19/24 | 39.50 on 07/08/24 | 66.34 on 07/09/24 | 377.85 on 12/19/24 |
| High | 18.68 on 08/26/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 19,479 | 139,000,656 | 114,957,072 | 113,696,848 | 103,652,840 |
| Shares Outstanding, K | 1,320 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 42,810,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -24,540,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | -3,590,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 0.67 | 0.56 | 0.45 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.19 on 11/13/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | N/A | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.620 on 01/03/25 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.59 | 48.35 | 20.63 | 0.00 |